Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.695
Change: 0.00 (0.00%)
Spread: 0.695 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter, 2021 Results

17 Nov 2021 07:27

RNS Number : 6577S
EFG-Hermes Holdings SAE
17 November 2021
 

http://www.rns-pdf.londonstockexchange.com/rns/6577S_1-2021-11-17.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6577S_2-2021-11-17.pdf

EFG HERMES REPORTS THIRD QUARTER 2021

GROUP EARNINGS OF EGP356 MILLION; ON OPERATING REVENUE OF EGP1.2 BILLION

Cairo, November 17th, 2021 - EFG Hermes reports a strong set of results for the third quarter of 2021, with Group earnings of EGP356 million on operating revenues of EGP1.2 billion. The Group's total assets stood at EGP49.6 billion at the end of September 2021.

Key Highlights

3Q21

· Third quarter denotes a significant improvement in the operational performance of the Group's business lines; despite Group headline revenues retreating 17% Y-o-Y to EGP1.2 billion in 3Q21, as the comparable quarter included strong incentive fees from Private Equity's Vortex III exit of EGP349 million and included strong unrealized gains on seed capital revaluation;

· The strong operational performance in the three quarters of 2021, underpinned the Group revenues, which rose 8% Y-o-Y to EGP4.0 billion in 9M21; an outstanding performance given that the comparable period included Private Equity's exit of Vortex III and strong unrealized and realized gains on investments booked in 9M20;

· With Group expenses broadly flat in 9M21, inching down 1% Y-o-Y to EGP2.5 billion; the Group reported in 9M21a net operating profit and a net profit after tax and minority interest up 30% Y-o-Y and 26% Y-o-Y to EGP1.5 billion and EGP1.1 billion, respectively;

· Sell-side revenues rose 45% Y-o-Y to EGP406 million in 3Q21, on strong revenues booked by Investment Banking and Brokerage. Investment Banking revenues almost tripled rising 184% to reach EGP107 million, on stronger advisory fees and higher deal count. Brokerage revenues gained 23% Y-o-Y to EGP299 million, on higher revenues reported particularly by Egypt operations, followed by Kuwait and the Structured Product desk;

· The buy-side revenues declined 74% Y-o-Y to EGP115 million in 3Q21, albeit Asset Management revenues increasing Y-o-Y, as the comparable quarter included EGP349 million of Private Equity incentive fees from Vortex III exit. Asset Management revenues added 32% Y-o-Y to EGP86 million in 3Q21; largely due to higher management fees reported by FIM. Private Equity revenues came at EGP29 million in 3Q21 versus EGP381 million in 3Q20;

· NBFIs revenue grew 52% Y-o-Y to EGP507 million in 3Q21 as Tanmeyah and valU added another quarter of strong performance. Tanmeyah reported revenues of EGP355 million, up 36% Y-o-Y, on stronger sales and enhanced margins. valU continued to outperform, with its revenues growing more than threefold Y-o-Y to reach EGP97 million, on Y-o-Y portfolio expansion and better margins. Leasing and Factoring revenues gained 17% Y-o-Y and 28% Y-o-Y to EGP44 million and EGP10 million respectively, on larger portfolio;

· Capital markets & treasury operations reported a weak quarter, with its revenues losing 58% Y-o-Y to reach EGP156 million in 3Q21; mainly on unrealized losses related to seed capital revaluation, while the comparable quarter included strong unrealized gains related to seed capital revaluation;

· Group operating expenses declined 14% Y-o-Y to EGP760 million in 3Q21; predominately on lower employee expenses, which came on the back of lower bonus provisions Y-o-Y. Thus, employee expenses/ revenues came at 44% in 3Q21, lower Y-o-Y and Q-o-Q;

· Group reported a net operating profit and a net profit after tax and minority interest of EGP424 million and EGP356 million in 3Q21, respectively. If we normalized earnings by excluding the exceptional Private Equity's incentive fees booked in the comparable quarter, the Group net operating profit and net profit after tax and minority interest would be up 108% Y-o-Y and 387% Y-o-Y, respectively.

 

For full report and financial statements, please click on the links on top of the page.

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Group Head of IR, Budgeting and Reporting

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

www.efg-hermes.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFIFFDLSLDLIL
Date   Source Headline
8th May 20127:00 amRNSRe Agreement
26th Apr 20129:23 amRNSStatement re. Press Comment
25th Apr 20123:45 pmRNSSecond Price Monitoring Extn
25th Apr 20123:40 pmRNSPrice Monitoring Extension
10th Apr 20127:00 amRNSFY2011 Results
28th Mar 20129:36 amRNSStatement re Damas International Limited
26th Mar 20128:49 amRNSStatement re Strategic Alliance with QInvest
19th Mar 201211:07 amRNSStatement re. Press Comment
14th Feb 20129:33 amRNSStatement re CEO Travel Ban
8th Feb 20128:33 amRNSStatement re CEO Travel Ban
6th Feb 20127:42 amRNSStatement re - CEO Travel Ban
17th Jan 20123:45 pmRNSSecond Price Monitoring Extn
17th Jan 20123:40 pmRNSPrice Monitoring Extension
16th Nov 20119:28 amRNS3rd Quarter Results
10th Oct 20113:45 pmRNSSecond Price Monitoring Extn
10th Oct 20113:40 pmRNSPrice Monitoring Extension
4th Oct 20119:53 amRNSStatement re. Press Comment
19th Sep 20113:45 pmRNSSecond Price Monitoring Extn
19th Sep 20113:40 pmRNSPrice Monitoring Extension
19th Sep 20112:00 pmRNSStatement re Bonus Shares Distribution
2nd Sep 20113:40 pmRNSPrice Monitoring Extension
15th Aug 20117:00 amRNS2nd Quarter results
11th Aug 20113:45 pmRNSSecond Price Monitoring Extn
11th Aug 20113:40 pmRNSPrice Monitoring Extension
1st Aug 20113:45 pmRNSSecond Price Monitoring Extn
1st Aug 20113:40 pmRNSPrice Monitoring Extension
19th Jul 20113:45 pmRNSSecond Price Monitoring Extn
19th Jul 20113:40 pmRNSPrice Monitoring Extension
13th Jul 20113:45 pmRNSSecond Price Monitoring Extn
13th Jul 20113:40 pmRNSPrice Monitoring Extension
6th Jul 201111:53 amRNSRegulatory Approval
27th Jun 20113:45 pmRNSSecond Price Monitoring Extn
27th Jun 20113:40 pmRNSPrice Monitoring Extension
15th Jun 20119:28 amRNS1st Quarter Results
13th Jun 201110:36 amRNSEGM & AGM Statement
6th Jun 20117:00 amRNSTreasury Stock
25th May 20119:29 amRNSNotice of AGM & EGM
10th May 20113:40 pmRNSPrice Monitoring Extension
5th May 20113:45 pmRNSSecond Price Monitoring Extn
5th May 20113:40 pmRNSPrice Monitoring Extension
4th May 20113:40 pmRNSPrice Monitoring Extension
28th Apr 20113:40 pmRNSPrice Monitoring Extension
27th Apr 20111:12 pmRNSStatement re Board of Directors
26th Apr 20113:40 pmRNSPrice Monitoring Extension
26th Apr 201110:32 amRNSStatement re Board of Directors
18th Apr 20119:51 amRNSDirectorate Change
30th Mar 20112:19 pmRNSStatement re news published on the company
30th Mar 20119:47 amRNSAnnual Financial Report
29th Mar 20115:00 pmRNSDirectorate Change
14th Feb 20117:10 amRNSStatement re clarification of ownership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.